{
    "organizations": [],
    "uuid": "d3d95c14044c075ecfe76b6a44caedd5c30ab7d6",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-oncolytics-biotech-says-has-applie/brief-oncolytics-biotech-says-has-applied-to-list-its-common-shares-on-nasdaq-idUSFWN1ST0Q1",
    "ord_in_thread": 0,
    "title": "BRIEF-Oncolytics Biotech Says Has Applied To List Its Common Shares On Nasdaq",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 22 (Reuters) - Oncolytics Biotech Inc:\n* ONCOLYTICS BIOTECHÂ® HAS APPLIED TO LIST ITS COMMON SHARES ON NASDAQ AND ANNOUNCES SHARE CONSOLIDATION\n* ONCOLYTICS BIOTECH - BOARD DETERMINED SHARE CONSOLIDATION TO BE DONE ON BASIS OF 1 NEW SHARE FOR EVERY 9.5 CURRENTLY OUTSTANDING SHARES Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-23T05:20:00.000+03:00",
    "crawled": "2018-05-23T15:26:27.001+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "oncolytics",
        "biotech",
        "inc",
        "oncolytics",
        "applied",
        "list",
        "common",
        "share",
        "nasdaq",
        "announces",
        "share",
        "consolidation",
        "oncolytics",
        "biotech",
        "board",
        "determined",
        "share",
        "consolidation",
        "done",
        "basis",
        "new",
        "share",
        "every",
        "currently",
        "outstanding",
        "share",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}